At a glance
ClinicalIndex Comparison RecordPhase 1Completed· 24 enrolled
Drug / intervention
Lisdexamfetamine Dimesylate +1 moredrug
Likely dose
Lisdexamfetamine Dimesylate 50mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Phase I, Open-Label, Randomized, Four Period Crossover Drug Interaction Study to Evaluate the Pharmacokinetic Profiles of VYVANSE™ and ADDERALL XR When Each is Administered Alone and in Combination With the Proton Pump Inhibitor Prilosec OTC™ in Healthy Adult Volunteers
In Brief
A Phase 1 clinical trial evaluating Lisdexamfetamine Dimesylate and Adderall XR (mixed salts amphetamine) for Healthy Volunteers. Completed, enrolled 24 participants across 1 site.
Detailed Summary
The purpose of this study is to determine if taking Vyvanse with Prilosec OTC or Adderall XR with Prilosec OTC changes how quickly the drug is absorbed into the body and/or changes how much of the drug is absorbed into the body.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHealthy Volunteers
CountriesUnited States
Collaborators--
Timeline
Phase 1CompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
First PostedSep 2008
Enrollment StartSep 2008
Primary CompletionOct 2008
TodayJul 2026
First PostedSep 4, 2008
Enrollment StartSep 8, 2008
Primary CompletionOct 26, 2008
TodayJul 2, 2026
Enrollment to primary: 2 monthsPosted 17.8 years ago
Interventions
Lisdexamfetamine Dimesylatedrug
50mg capsule
Adderall XR (mixed salts amphetamine)drug
20mg capsule